Attach a lungtargeted, enzymecleavable carbonate to the ether oxygen, forming a prodrug that limits pulmonary accumulation, reducing fibrosis risk
A 0.5 mL syringe is comfortable for 1.0 mg (40 units)
For patients with type 2 diabetes or obesity who are interested in GLP-1 therapies, discuss the currently licensed options with your GP, practice nurse, or diabetes specialist nurse
Our office also provides injections of vitamin C for an immune boost
Research Applications Comprehensive musculoskeletal repair research Tendon and ligament regeneration studies Wound healing and skin repair models Inflammation modulation research Synergistic dual-peptide mechanism studies Quality Specifications Purity: 98% (HPLC verified) Compound: BPC-157 + TB-500 Molecular Weight: 1419.5 Da / 2113.4 Da Form: Lyophilized powder Origin: Made in the USA Testing: Third-party tested in a US laboratory Storage: -20C, protect from light COA: Batch-specific, ISO-accredited laboratory Frequently Asked Questions Q: Why combine BPC-157 and TB-500
The KPV component of KLOW blend specifically contributes to this research direction